Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3008364	s-lipoa1	g/l (g/l)	15755	16694	0.00%
3008364	fs-lipoa1	g/l (g/l)	3069	4088	0.00%
3008364	p-lipoa1	g/l_______ (g/l)	110	116	0.00%
3008364	s-lipoa1	— (—)	81	86	100.00%	Distribution not available
3008364	p-lipoa1	g/l (g/l)	20	20	0.00%
3008364	s-ngapob	g/l (g/l)	7	10	0.00%	Distribution not available
3008364	s-ngapoa1	g/l (g/l)	7	10	0.00%	Distribution not available
3008364	fs-lipoa1	g/l_______ (g/l)	5	6	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Unspecified mental disorder

275

10259

0.26

122.86

1.1

1.51

1.50

g/l

0.26

275

10250

Kela-code for severe mental illness

203

8987

0.22

120.75

1.1

1.49

g/l

0.02

203

8979

Schizophrenia or delusion, excluding more controls

196

8658

0.21

119.30

1.1

1.49

g/l

0.18

196

8651

525

11810

0.39

105.26

1.1

1.50

1.48

g/l

0.77

525

11800

Schizophrenia, schizotypal and delusional disorders

195

7988

0.24

102.46

1.1

1.49

g/l

0.07

195

7980

Schizophrenia or delusion

196

7988

0.24

102.14

1.1

1.49

g/l

0.09

196

7980

Implicit Sepsis

614

10617

0.42

101.89

1.2

1.1

1.51

g/l

0.08

614

10609

Alcohol use disorder, Swedish definition

480

11172

0.38

100.13

1.1

1.50

1.48

g/l

0.97

480

11162

605

12249

0.42

99.93

1.1

1.50

1.48

g/l

0.62

605

12239

Mental and behavioural disorders due to alcohol

458

11328

0.38

98.98

1.1

1.52

1.48

g/l

2.28

458

11319

Mental and behavioural disorders due to alcohol, excluding acute intoxication

323

9676

0.32

96.74

1.1

1.53

1.48

g/l

3.06

323

9669

Mood disorders

1586

17029

0.59

91.59

1.1

1.52

1.51

g/l

0.87

1581

17016

Alcohol use disorder, ICD-based

296

9080

0.32

91.42

1.1

1.53

1.48

g/l

3.12

296

9075

Mood [affective] disorders

1589

17025

0.59

90.37

1.1

1.52

1.51

g/l

0.95

1584

17012

Depression

1528

17005

0.59

85.67

1.1

1.53

1.51

g/l

1.08

1523

16992

All kidney diseases

1461

16074

0.60

77.35

1.1

1.51

1.52

g/l

1.50

1456

16062

Diabetes mellitus

1745

15774

0.63

73.96

1.2

1.1

1.44

1.53

g/l

44.02

1740

15762

Diabetes medication

1727

15781

0.63

73.05

1.2

1.1

1.43

1.53

g/l

47.85

1722

15769

Diabetes, varying definitions

1738

15736

0.63

72.90

1.2

1.1

1.43

1.53

g/l

45.64

1733

15724

Type 2 diabetes

1624

14777

0.63

70.19

1.2

1.1

1.42

1.53

g/l

57.44

1619

14765

Polyarthropathies

947

10865

0.55

69.39

1.1

1.52

g/l

0.31

947

10856

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

364

8566

0.41

65.46

1.1

1.58

1.52

g/l

3.37

364

8560

STROKE

597

7978

0.49

62.41

1.2

1.1

1.47

1.53

g/l

6.45

597

7973

Cerebrovascular diseases (FINNGEN)

369

6040

0.42

61.66

1.2

1.1

1.46

1.54

g/l

7.67

369

6034

Conductive and sensorineural hearing loss

775

9045

0.56

53.39

1.2

1.52

1.53

g/l

0.55

775

9039

Care involving use of rehabilitation procedures

829

12769

0.57

53.30

1.1

1.52

g/l

0.45

829

12759

Hard cardiovascular diseases

1165

10926

0.62

52.85

1.2

1.1

1.46

1.53

g/l

16.68

1165

10917

Heart failure,strict

171

3678

0.32

51.97

1.2

1.45

1.49

g/l

1.23

171

3678

Heart failure, strict

175

3635

0.33

49.90

1.2

1.45

1.49

g/l

1.25

175

3635

Poisoning by drugs, medicaments and biological substances

244

6074

0.39

48.74

1.1

1.55

1.51

g/l

1.35

244

6069

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

364

7737

0.46

48.35

1.1

1.58

1.52

g/l

3.09

364

7729

Heart failure and antihypertensive medication

133

2897

0.29

48.20

1.2

1.1

1.45

1.53

g/l

2.70

133

2897

All-cause Heart Failure

169

3513

0.33

48.20

1.2

1.46

1.49

g/l

0.96

169

3513

Other reaction to severe stress, and adjustment disorders

612

10982

0.54

47.96

1.1

1.52

g/l

0.39

612

10971

Type 2 diabetes, definitions combined, including avohilmo

1655

13861

0.68

47.69

1.2

1.1

1.42

1.54

g/l

69.63

1650

13852

Sensorineural hearing loss

666

7886

0.56

47.67

1.2

1.52

1.53

g/l

0.17

666

7881

Ischemic heart diseases

1101

10273

0.63

47.21

1.2

1.1

1.46

1.52

g/l

13.88

1101

10264

Other heart diseases

1047

10649

0.63

45.86

1.1

1.47

1.53

g/l

12.68

1047

10639

Bipolar affective disorders

195

5173

0.36

45.34

1.1

1.53

1.52

g/l

0.12

195

5168

Other heart diseases, wide

1841

15635

0.70

44.66

1.1

1.48

1.52

g/l

8.95

1841

15619

Major coronary heart disease event

1057

9812

0.64

43.27

1.2

1.1

1.46

1.52

g/l

13.94

1057

9803

Other arrhythmias

974

11194

0.64

39.42

1.1

1.50

1.53

g/l

3.78

974

11185

Coronary revascularization (ANGIO or CABG)

1044

9490

0.66

36.02

1.2

1.1

1.46

1.52

g/l

13.75

1044

9482

Emergency coronary revascularization (for ACS)

1066

9573

0.66

35.53

1.2

1.1

1.45

1.52

g/l

14.15

1066

9565

Cardiac arrhythmias

1369

12414

0.70

35.47

1.1

1.49

1.54

g/l

11.92

1369

12405

Percutaneous Coronary Intervention

1046

9483

0.66

35.40

1.2

1.1

1.46

1.52

g/l

13.42

1046

9475

Sciatica+with lumbago

807

10900

0.65

31.89

1.1

1.52

1.53

g/l

0.43

807

10892

Malignant neoplasm of digestive organs, including Hilmo

218

3546

0.45

31.30

1.2

1.53

1.51

g/l

0.51

218

3546

Other neurological diseases

715

8658

0.63

30.90

1.2

1.1

1.51

1.52

g/l

0.54

715

8653

Heart failure and coronary heart disease

116

2324

0.35

30.49

1.1

1.2

1.42

1.49

g/l

2.12

116

2324

ILD medications: immunosuppressive drugs

1116

14293

0.70

29.58

1.1

1.52

1.51

g/l

0.24

1116

14278

Diverticular disease of intestine

870

8021

0.67

28.55

1.2

1.53

g/l

0.25

870

8016

Malignant neoplasm of digestive organs

178

3123

0.43

28.24

1.2

1.55

1.51

g/l

1.25

178

3123

Other disorders of fluid, electrolyte and acid-base balance

138

3274

0.39

27.89

1.2

1.54

1.52

g/l

0.27

138

3274

Phobic anxiety disorders

183

4047

0.44

27.88

1.1

1.55

1.51

g/l

1.02

183

4042

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2208

0.27

26.61

1.1

1.2

1.53

g/l

0.05

2208

Insomnia

2754

15399

1.26

26.27

1.1

1.52

1.51

g/l

0.48

2748

15389

COPD related to multimorbidity

2289

0.34

25.68

1.1

1.2

1.52

1.51

g/l

0.12

2289

Gonarthrosis [arthrosis of knee](FG)

1180

9322

0.72

24.97

1.2

1.1

1.52

1.53

g/l

1.16

1180

9317

Non-ischemic cardiomyopathy

2168

0.36

24.46

1.2

1.43

1.51

g/l

2.07

2168

Examination and observation for other reasons

1228

9398

0.73

24.16

1.1

1.51

g/l

0.24

1228

9390

Sleep disorders

2735

15282

1.24

23.92

1.1

1.52

1.51

g/l

0.41

2729

15273

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

686

8869

0.67

23.66

1.2

1.51

1.53

g/l

0.84

686

8863

Shoulder lesions

1334

10670

0.74

23.59

1.1

1.52

g/l

0.23

1334

10663

Use of disulfiram, acamprosate or naltrexone

2093

0.31

22.39

1.1

1.55

1.47

g/l

1.20

2093

Symptoms and signs involving the nervous and musculoskeletal systems

706

10285

0.68

22.28

1.1

1.51

1.53

g/l

1.15

706

10276

Peripheral artery disease

131

2435

0.42

22.26

1.2

1.45

1.50

g/l

1.21

131

2435

Mental retardation, excluding more controls

741

0.10

21.77

1.0

1.1

1.37

1.48

g/l

—

741

Other specified and unspecified personality disorders

2092

0.32

21.68

1.1

1.53

1.52

g/l

0.14

2092

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1752

0.26

21.59

1.2

1.49

g/l

0.05

1752

Hypertensive heart and/or renal disease

1634

0.34

21.49

1.2

1.39

1.51

g/l

4.23

1634

Behavioural syndromes associated with physiological disturbances and physical factors

2757

15341

1.23

21.14

1.1

1.52

1.51

g/l

0.46

2751

15332

Mixed and other personality disorders

2029

0.33

20.52

1.1

1.53

1.51

g/l

0.28

2029

COPD, hospital admission 2, with asthma infections

2085

0.38

20.06

1.1

1.2

1.52

1.51

g/l

0.12

2085

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

457

6126

0.64

19.40

1.1

1.48

1.49

g/l

0.67

457

6118

Alcoholic liver disease

1267

0.19

18.73

1.1

1.2

1.48

g/l

0.01

1267

Presence of cardiac and vascular implants and grafts

221

2999

0.54

18.57

1.2

1.43

1.48

g/l

2.34

221

2999

Continuous positive airway pressure

222

3374

0.54

18.49

1.1

1.42

1.52

g/l

7.00

222

3374

Generalized anxiety disorder

279

4728

0.58

18.22

1.1

1.52

1.53

g/l

0.33

279

4722

Mental retardation, wide definition

667

0.11

18.12

1.0

1.1

1.36

1.49

g/l

—

667

Fall on same level

2512

16119

0.82

18.04

1.1

1.51

g/l

0.46

2507

16106

Hypertensive Heart Disease

1425

0.34

17.83

1.2

1.38

1.51

g/l

4.39

1425

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1683

0.31

17.82

1.2

1.57

1.53

g/l

0.53

1683

Alcohol withdrawal state with delirium

1042

0.14

17.76

1.3

1.2

1.57

1.46

g/l

1.06

1042

Mental retardation

644

0.12

17.33

1.0

1.1

1.37

1.49

g/l

—

644

Second line medication for Crohn's disease

932

12415

0.74

17.33

1.1

1.52

g/l

0.15

932

12403

Fibromyalgia

2137

0.40

17.32

1.1

1.55

1.60

g/l

0.92

2137

Mental and behavioural disorders due to tobacco

1495

0.29

17.17

1.2

1.1

1.51

1.53

g/l

0.27

1495

Atherosclerosis, excluding cerebral and coronary sclerosis

104

1890

0.43

17.06

1.2

1.43

1.50

g/l

1.99

104

1890

Codes for special purposes

780

10549

0.73

16.89

1.1

1.51

1.52

g/l

0.73

780

10539

Smoking dependency

1476

0.29

16.77

1.2

1.1

1.51

1.53

g/l

0.28

1476

Provisional assignment of new diseases of uncertain etiology

780

10538

0.73

16.77

1.1

1.51

1.52

g/l

0.72

780

10528

Other symptoms and signs involving the nervous and musculoskeletal systems

548

7859

0.69

16.10

1.1

1.51

1.53

g/l

1.33

548

7854

Persistent delusional disorders

1187

0.23

16.05

1.2

1.40

1.51

g/l

1.74

1187

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1287

0.32

15.90

1.2

1.50

1.52

g/l

0.22

1287

L04AX Other immunosuppressants

892

11791

0.75

15.71

1.1

1.53

1.52

g/l

0.21

892

11779

COPD, hospital admissions 3, with asthma pneumonia sepsis

1350

0.33

15.52

1.2

1.50

1.51

g/l

0.12

1350

Fentanyl

861

0.11

15.50

1.1

1.2

1.56

1.54

g/l

—

861

Other special examinations and investigations of persons without complaint or reported diagnosis

1497

9454

0.80

15.28

1.1

1.50

1.51

g/l

0.74

1497

9446

Retention of urine

183

2708

0.54

15.19

1.2

1.49

1.50

g/l

0.24

183

2708

Degenerative diseases of the nervous system

806

0.22

15.15

1.2

1.3

1.59

1.52

g/l

0.48

806

Any dementia, excluding more controls

903

0.28

15.11

1.1

1.3

1.55

1.54

g/l

0.08

903

Diabetic maculopathy, excluding more controls

1797

0.39

15.08

1.1

1.46

1.49

g/l

0.33

1797

Arthrosis

1416

9697

0.79

14.94

1.2

1.1

1.51

1.52

g/l

1.64

1416

9691

Lung cancer and mesothelioma

1057

0.27

14.87

1.2

1.53

1.54

g/l

0.05

1057

Panic disorder

260

4225

0.60

14.40

1.1

1.51

1.52

g/l

0.49

260

4219

Chronic pancreatitis

1688

0.38

14.33

1.1

1.2

1.46

1.49

g/l

0.23

1688

Ill-defined and unknown causes of mortality

593

0.15

14.23

1.6

1.2

1.44

1.49

g/l

—

593

Hyperlipidaemia, other/unspecified

258

3795

0.61

14.18

1.2

1.48

1.50

g/l

0.64

258

3795

Use of biperiden

826

0.14

14.18

1.0

1.1

1.54

1.51

g/l

0.15

826

Malignant neoplasm of respiratory system and intrathoracic organs

1092

0.31

14.06

1.2

1.51

1.52

g/l

0.10

1092

Injuries to the elbow and forearm

1300

13877

0.80

13.98

1.1

1.53

1.52

g/l

0.92

1300

13863

Hypo-osmolality and hyponatraemia

1547

0.37

13.94

1.2

1.56

1.53

g/l

0.34

1547

COPD, hospital admissions 1, only main diagnosis

112

1988

0.48

13.70

1.1

1.2

1.54

1.51

g/l

0.60

112

1988

Malignant neoplasm of bronchus and lung, including Hilmo

990

0.28

13.65

1.2

1.53

1.52

g/l

0.05

990

Ulcer of lower limb, not elsewhere classified

1230

0.30

13.41

1.2

1.46

1.50

g/l

0.53

1230

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1203

0.42

12.56

1.2

1.53

1.55

g/l

0.22

1203

Any dementia

817

0.31

12.45

1.1

1.3

1.55

1.53

g/l

0.10

817

Covid-19 confirmed case

387

5613

0.68

12.29

1.2

1.1

1.52

g/l

0.08

387

5608

Polyarthrosis

105

1914

0.49

12.28

1.3

1.2

1.56

1.59

g/l

0.65

105

1914

Sulfonylureas

1351

0.43

12.11

1.2

1.3

1.40

1.53

g/l

3.51

1351

Cerebral palsy and other paralytic syndromes

1748

0.44

12.11

1.2

1.1

1.53

1.52

g/l

0.12

1748

Opioids

2343

14141

0.85

12.07

1.1

1.49

1.52

g/l

4.79

2336

14134

Hernia

1842

14539

0.84

11.96

1.1

1.47

1.52

g/l

13.31

1842

14525

Other CVD (FINNGEN)

998

0.36

11.92

1.4

1.2

1.48

1.54

g/l

1.15

998

L04AD Calcineurin inhibitors

101

2026

0.49

11.83

1.1

1.46

1.51

g/l

0.80

101

2026

Acute renal failure

2001

0.49

11.81

1.2

1.53

1.49

g/l

0.54

2001

Asthma-related infections

985

12073

0.79

11.72

1.1

1.51

1.52

g/l

0.34

985

12062

Asthma, hospital admission 2, infections

985

12073

0.79

11.72

1.1

1.51

1.52

g/l

0.34

985

12062

Hyperplasia of prostate

375

3078

0.68

11.60

1.2

1.43

1.42

g/l

0.19

375

3078

Other ill-defined and unspecified causes of mortality

513

0.17

11.46

1.6

1.2

1.44

1.50

g/l

—

513

Transplanted organ and tissue status

1642

0.45

11.27

1.1

1.2

1.48

1.49

g/l

0.15

1642

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1298

0.39

10.94

1.2

1.1

1.52

1.51

g/l

0.03

1298

Cardiomyopathy (excluding other)

1354

0.41

10.72

1.0

1.2

1.40

1.48

g/l

2.01

1354

Malignant neoplasm of bronchus and lung

801

0.30

10.63

1.3

1.52

g/l

0.01

801

Other diseases of the respiratory system

1627

0.46

10.54

1.2

1.48

1.52

g/l

0.66

1627

Other respiratory disorders and diseases

1627

0.46

10.54

1.2

1.48

1.52

g/l

0.66

1627

Asthma (only as main-diagnosis), excluding more controls

1666

10926

0.84

10.53

1.1

1.52

g/l

0.35

1666

10917

Reimbursement for rheumatic diseases

837

10517

0.78

10.53

1.1

1.54

g/l

0.01

837

10508

Cardiomyopathies, Primary/intrinsic

1325

0.41

10.46

1.0

1.2

1.40

1.48

g/l

1.86

1325

Persons encountering health services for specific procedures, not carried out

1807

0.49

10.42

1.2

1.1

1.46

1.51

g/l

0.99

1807

Gout

162

2356

0.59

10.39

1.2

1.41

1.47

g/l

2.13

162

2356

Ascites

791

0.25

10.31

1.0

1.2

1.69

1.53

g/l

1.15

791

Supplementary factors related to causes of morbidity and mortality classified elsewhere

463

6306

0.73

10.22

1.1

1.51

1.50

g/l

0.23

463

6301

Nontraumatic intracranial haemmorrhage

1644

0.48

10.15

1.2

1.51

1.52

g/l

0.22

1644

Other or unspecified ileus, impaction or obstruction

1904

0.51

10.06

1.1

1.2

1.49

1.52

g/l

0.66

1904

Dissociative [conversion] disorders

856

0.29

9.92

1.1

1.55

1.56

g/l

0.07

856

malignant neoplasm of male genital organs, including Hilmo

226

2115

0.64

9.91

1.3

1.2

1.43

1.42

g/l

0.34

226

2115

Asthma (only as main-diagnosis)

1670

11000

0.84

9.79

1.1

1.52

g/l

0.28

1670

10991

Cardiomyopathy

113

2063

0.54

9.72

1.1

1.2

1.44

1.50

g/l

1.74

113

2063

Alcohol-induced chronic pancreatitis

1001

0.35

9.69

1.2

1.41

1.46

g/l

0.42

1001

Dilated cardiomyopathy

1167

0.40

9.66

1.0

1.2

1.39

1.47

g/l

1.51

1167

Unstable angina pectoris

183

2318

0.62

9.54

1.3

1.2

1.43

1.50

g/l

3.99

183

2318

Delirium, not induced by alcohol and other psychoactive substances

783

0.28

9.43

1.2

1.71

1.49

g/l

1.64

783

Extracorporeal dialysis

712

0.25

9.38

1.1

1.2

1.38

1.48

g/l

0.96

712

Polyneuropathies and other disorders of the peripheral nervous system

132

2280

0.57

9.28

1.2

1.52

1.51

g/l

0.14

132

2280

Invasive ventilation

893

0.33

9.25

1.2

1.54

1.51

g/l

0.28

893

Disorders of other endocrine glands

662

8321

0.78

9.16

1.1

1.47

1.52

g/l

5.41

662

8314

malignant neoplasm of male genital organs

212

1980

0.64

9.14

1.3

1.2

1.43

1.42

g/l

0.12

212

1980

Obesity, other/unspecified

650

8307

0.77

9.13

1.1

1.48

1.55

g/l

9.81

650

8301

Codeine

2255

13962

0.87

9.07

1.1

1.49

1.52

g/l

4.47

2247

13956

Status post-ami

1255

0.50

9.05

1.4

1.2

1.41

1.48

g/l

1.64

1255

severe traumatic brain injury, does not include concussion

136

2308

0.58

8.95

1.1

1.2

1.47

1.49

g/l

0.26

136

2308

Rheumatism, unspecified

105

1900

0.55

8.85

1.1

1.2

1.54

1.60

g/l

1.90

105

1900

Nonischemic cardiomyopathy

1105

0.41

8.81

1.2

1.37

1.48

g/l

2.92

1105

Osteoporosis

106

1758

0.55

8.70

1.1

1.2

1.62

1.57

g/l

1.52

106

1758

Unspecific neurodegenerative disorder

691

0.39

8.59

1.2

1.3

1.55

1.53

g/l

0.15

691

Anankastic personality disorder

879

0.35

8.57

1.1

1.64

1.54

g/l

0.84

879

Kidney transplant status

882

0.35

8.54

1.1

1.2

1.46

1.49

g/l

0.28

882

Agoraphobia

915

0.37

8.48

1.1

1.48

1.52

g/l

0.45

915

Other mental disorders due to brain damage and dysfunction and to physical disease

858

0.35

8.46

1.2

1.54

1.51

g/l

0.30

858

Subarachnoid haemorrhage

1029

0.40

8.42

1.2

1.49

1.54

g/l

0.58

1029

Manic episode

642

0.26

8.40

1.0

1.1

1.60

1.51

g/l

0.54

642

Pneumonitis due to solids and liquids

668

0.27

8.37

1.1

1.2

1.45

1.49

g/l

0.28

668

Amputation

652

0.26

8.35

1.4

1.2

1.43

1.48

g/l

0.37

652

Obesity related asthma

512

6665

0.76

8.31

1.2

1.1

1.48

1.53

g/l

4.64

512

6660

Abnormal involuntary movements

115

1989

0.57

8.27

1.1

1.55

1.53

g/l

0.31

115

1989

Elevated blood glucose level

1239

0.46

8.26

1.2

1.45

1.52

g/l

0.84

1239

Hyperkinetic disorders

298

4081

0.70

8.25

1.0

1.1

1.49

g/l

0.01

298

4076

Alzheimer disease, excluding more controls

401

0.24

8.19

1.1

1.3

1.55

g/l

0.02

401

Intentional self-harm by sharp object

564

0.22

8.13

1.0

1.1

1.71

1.50

g/l

1.20

564

Disturbance of activity and attention

286

3931

0.70

8.07

1.0

1.1

1.50

g/l

0.03

286

3926

Hypokalaemia

1392

0.50

8.03

1.3

1.2

1.52

1.55

g/l

0.42

1392

Unspecified fall

741

9014

0.80

7.94

1.1

1.50

1.51

g/l

0.11

741

9005

Other and unspecified polyneuropathies, also in other diseases

109

1891

0.57

7.88

1.2

1.52

1.51

g/l

0.14

109

1891

Malignant neoplasm of prostate, including Hilmo

189

1714

0.65

7.86

1.3

1.2

1.46

1.42

g/l

1.32

189

1714

833

10098

0.81

7.85

1.1

1.50

1.51

g/l

0.85

833

10089

Decubitus ulcer and pressure area

383

0.21

7.83

1.0

1.2

1.54

1.50

g/l

—

383

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

913

0.40

7.66

1.2

1.50

1.51

g/l

0.08

913

Injuries to the abdomen, lower back, lumbar spine and pelvis

546

6859

0.78

7.52

1.1

1.52

1.51

g/l

0.75

546

6854

Schizoid personality disorder

332

0.17

7.51

1.7

1.1

1.61

1.48

g/l

—

332

Gastroduodenal ulcer

139

2233

0.62

7.47

1.2

1.52

1.51

g/l

0.20

139

2233

Dialysis

538

0.24

7.45

1.1

1.2

1.42

1.48

g/l

0.37

538

Other neurotic disorders

634

0.29

7.44

1.2

1.53

g/l

0.04

634

Other dialysis

386

0.23

7.42

1.0

1.1

1.40

1.48

g/l

—

386

Peripheral artery operations in Hilmo

771

0.36

7.34

1.3

1.2

1.41

1.48

g/l

0.64

771

Malignant neoplasm of prostate

174

1585

0.65

7.32

1.3

1.2

1.45

1.43

g/l

0.74

174

1585

Parasetamol

2002

11515

0.87

7.31

1.1

1.48

1.51

g/l

7.06

1997

11509

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1074

0.46

7.29

1.1

1.57

1.53

g/l

0.48

1074

Non-small cell lung cancer, including Hilmo

722

0.36

7.28

1.3

1.52

1.53

g/l

0.02

722

Disorders of synovium and tendon

1110

11131

0.84

7.27

1.1

1.53

g/l

0.13

1110

11123

Psychotic depression

1187

0.49

7.19

1.1

1.58

1.53

g/l

0.76

1187

Volume depletion

747

0.36

7.18

1.0

1.2

1.39

1.51

g/l

1.31

747

Other disorders of glucose regulation and pancreatic internal secretion

1295

0.51

7.17

1.1

1.54

1.51

g/l

0.41

1295

Trochanteric bursitis

123

2010

0.61

7.12

1.1

1.2

1.59

1.60

g/l

0.08

123

2010

Agranulocytosis

1422

0.53

7.07

1.1

1.2

1.57

1.55

g/l

0.38

1422

Malignant neoplasm of brain, including Hilmo

691

0.34

7.06

1.2

1.46

1.50

g/l

0.29

691

Traumatic subdural haemorrhage

998

0.46

7.05

1.1

1.2

1.43

1.50

g/l

1.00

998

Gender identity disorders

296

0.16

7.03

1.0

1.1

1.33

1.50

g/l

—

296

Irritable bowel syndrome

439

5692

0.76

7.02

1.1

1.52

1.55

g/l

1.23

439

5687

Covid-19 suspected case

394

5168

0.75

6.95

1.1

1.50

1.53

g/l

1.74

394

5163

Colorectal cancer, including Hilmo

147

2136

0.64

6.85

1.2

1.54

1.52

g/l

0.66

147

2136

Sequelae of injuries of head

976

0.45

6.84

1.2

1.50

1.49

g/l

0.11

976

Trigger finger

174

2602

0.66

6.78

1.1

1.2

1.53

1.55

g/l

0.73

174

2602

Respiratory insufficiency

526

0.26

6.76

1.1

1.2

1.54

1.53

g/l

0.04

526

Alzheimer disease

437

0.31

6.73

1.2

1.3

1.59

1.54

g/l

0.24

437

Follow-up examination after treatment for conditions other than malignant neoplasms

922

7337

0.83

6.71

1.1

1.56

1.53

g/l

2.57

922

7330

Psoriatic arthropathies

120

1936

0.61

6.70

1.1

1.45

1.53

g/l

2.19

120

1936

Diseases of pulp and periapical tissues and dental caries

1238

7417

0.85

6.59

1.1

1.51

1.53

g/l

1.84

1238

7411

Malignant neoplasm of stomach, including Hilmo

364

0.24

6.58

1.0

1.2

1.63

1.51

g/l

—

364

Fracture of forearm

899

9633

0.83

6.58

1.1

1.55

1.53

g/l

1.67

899

9623

Enterocolitis due to Clostridium difficile

967

0.46

6.54

1.2

1.52

1.54

g/l

0.24

967

N06DA Anticholinesterases

533

0.36

6.54

1.3

1.60

1.54

g/l

0.55

533

Use of anticholinesterases

533

0.36

6.54

1.3

1.60

1.54

g/l

0.55

533

Malignant neoplasm of eye, brain and central nervous system

619

0.33

6.52

1.2

1.46

1.49

g/l

0.26

619

MS-disease / Multiple Sclerosis

1656

0.58

6.50

1.1

1.59

1.55

g/l

0.79

1656

Codeine or tramadol medication

2542

15366

0.89

6.50

1.1

1.50

1.52

g/l

3.72

2533

15358

malignant neoplasm of female genital organs, including Hilmo

1578

0.59

6.49

1.1

1.2

1.61

1.62

g/l

0.02

1578

Vitreous haemorrhage

1242

0.52

6.49

1.2

1.48

1.52

g/l

0.54

1242

Streptococcal septicaemia, including avohilmo

1003

0.47

6.48

1.1

1.2

1.48

1.51

g/l

0.27

1003

Alzheimer disease, including avohilmo

495

0.38

6.40

1.2

1.3

1.57

1.55

g/l

0.13

495

Assault by sharp object

431

0.22

6.35

1.0

1.1

1.48

1.45

g/l

—

431

Alcohol abuse counselling and surveillance

314

0.21

6.34

1.0

1.1

1.40

1.46

g/l

—

314

Cardiac arrest

655

0.41

6.28

1.3

1.2

1.43

1.51

g/l

1.12

655

Streptococcal septicaemia

970

0.48

6.15

1.1

1.2

1.48

1.50

g/l

0.27

970

Other symptoms and signs involving general sensations and perceptions

478

0.27

6.13

1.2

1.1

1.59

1.51

g/l

0.26

478

Hypoglycaemia, other or unspecified

1057

0.50

6.10

1.1

1.54

1.51

g/l

0.46

1057

Tobacco use

960

0.48

6.08

1.1

1.46

1.52

g/l

0.81

960

Gout, FINNGEN

162

2392

0.67

6.07

1.2

1.41

1.47

g/l

2.13

162

2392

Amputation of ankle bones

152

0.00

5.99

0.0

1.2

—

1.51

—

152

Drug-induced neutropenia

836

0.45

5.99

1.1

1.2

1.59

1.55

g/l

0.38

836

Malignant neoplasm of stomach

325

0.24

5.94

1.0

1.2

1.63

1.51

g/l

—

325

Colorectal cancer

126

1879

0.64

5.88

1.2

1.55

1.52

g/l

0.84

126

1879

Misadventures to patients during surgical and medical care

133

2037

0.65

5.87

1.1

1.53

1.55

g/l

0.34

133

2037

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1422

0.58

5.75

1.2

1.1

1.51

1.54

g/l

0.51

1422

Spinal instabilities

502

0.31

5.75

1.0

1.2

1.51

1.55

g/l

0.42

502

Pacemaker

156

2148

0.67

5.74

1.2

1.45

1.50

g/l

1.51

156

2148

Myocardial infarction, unclassifiable

847

0.49

5.68

1.3

1.2

1.43

1.49

g/l

0.80

847

Malignant neoplasm of brain

531

0.33

5.68

1.2

1.44

1.49

g/l

0.38

531

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1263

0.56

5.63

1.1

1.46

1.54

g/l

1.86

1263

Alcohol-induced acute pancreatitis

599

0.37

5.59

1.1

1.2

1.59

1.45

g/l

1.34

599

Psoriatic arthropathies, ICD10

118

1828

0.64

5.58

1.1

1.2

1.45

1.53

g/l

2.11

118

1828

Other and unspecified drugs and medicaments

1258

0.56

5.57

1.1

1.52

1.54

g/l

0.34

1258

Adrenocortical insufficiency

525

0.33

5.56

1.2

1.1

1.54

1.55

g/l

0.05

525

Dependent personality disorder

293

0.23

5.53

1.1

1.2

1.56

1.57

g/l

—

293

Diseases of oral cavity, salivary glands and jaws

1058

6349

0.85

5.51

1.1

1.52

1.51

g/l

0.35

1058

6344

Herpesviral [herpes simplex] infections, including avohilmo

696

5796

1.21

5.48

1.1

1.56

1.55

g/l

0.59

696

5790

COPD-related respiratory insufficiency

641

0.40

5.43

1.2

1.57

1.50

g/l

0.53

641

Status epilepticus

459

0.30

5.42

1.0

1.1

1.58

1.53

g/l

0.22

459

Other psoriatic arthropathies

116

1791

0.64

5.42

1.1

1.2

1.45

1.53

g/l

2.00

116

1791

Oesophageal varices

409

0.26

5.34

1.1

1.2

1.51

1.49

g/l

0.05

409

Diffuse brain injury

680

0.43

5.23

1.1

1.45

1.51

g/l

0.76

680

Fibrosis and cirrhosis of liver

774

0.47

5.12

1.3

1.2

1.55

1.54

g/l

0.17

774

Implicit fungal Sepsis, including avohilmo

760

0.47

5.11

1.1

1.56

1.55

g/l

0.06

760

Algoneurodystrophy

625

0.42

5.02

1.0

1.1

1.56

1.57

g/l

0.03

625

Gout, unspecified

1561

0.63

5.01

1.2

1.40

1.47

g/l

2.12

1561

Neuromuscular dysfunction of bladder

1133

0.57

5.01

1.1

1.48

1.52

g/l

0.52

1133

Diseases of the myoneural junction and muscle

1385

0.61

5.01

1.3

1.2

1.55

1.51

g/l

0.74

1385

Chronic laryngitis and laryngotracheitis

137

2013

0.67

4.99

1.1

1.2

1.51

1.55

g/l

1.06

137

2013

Other shoulder lesions

138

2019

0.67

4.98

1.1

1.45

1.54

g/l

4.02

138

2019

Hypotension

955

0.53

4.98

1.4

1.2

1.47

1.52

g/l

0.74

955

Cerebral aneurysm, nonruptured

1155

0.57

4.97

1.1

1.2

1.49

1.56

g/l

1.43

1155

Fall on same level involving ice and snow

1011

11641

0.86

4.94

1.1

1.53

1.52

g/l

0.48

1011

11630

Arthropathies in other diseases classified elsewhere

538

0.38

4.94

1.0

1.1

1.53

1.54

g/l

0.04

538

Hepatic failure, not elsewhere classified

405

0.29

4.93

1.0

1.2

1.44

1.52

g/l

0.30

405

Other disorders of skin and subcutaneous tissue, not elsewhere classified

117

1769

0.66

4.92

1.1

1.2

1.47

1.54

g/l

2.24

117

1769

Coronary artery bypass grafting

1011

0.61

4.91

1.3

1.2

1.39

1.47

g/l

2.97

1011

Gout, idiopatic and unspecified

136

1998

0.68

4.90

1.2

1.41

1.47

g/l

2.02

136

1998

Other and unspecified myopathies

852

0.51

4.85

1.4

1.2

1.54

1.49

g/l

0.52

852

Adhesive capsulitis of shoulder

187

2586

0.72

4.84

1.2

1.57

1.55

g/l

0.46

187

2586

Lichen simplex chronicus and prurigo

860

0.52

4.80

1.1

1.2

1.50

1.55

g/l

0.60

860

Complications of internal orthopaedic prosthetic devices, implants and grafts

129

1906

0.67

4.80

1.2

1.53

1.54

g/l

0.20

129

1906

Human immunodeficiency virus [HIV] disease, including avohilmo

452

0.34

4.80

1.1

1.46

1.45

g/l

0.08

452

526

0.39

4.77

1.2

1.1

1.51

1.54

g/l

0.23

526

Disorders resulting from impaired renal tubular function

427

0.32

4.77

1.0

1.1

1.47

1.50

g/l

0.12

427

Human immunodeficiency virus [HIV] disease

449

0.34

4.74

1.1

1.46

1.45

g/l

0.08

449

Other and unspecified injuries of head

1075

0.57

4.73

1.1

1.53

1.50

g/l

0.35

1075

Osteomyelitis

737

0.48

4.73

1.1

1.53

1.49

g/l

0.37

737

Amputation of toe

458

0.35

4.73

1.4

1.2

1.46

1.50

g/l

0.25

458

Dementia in Alzheimer disease

199

0.21

4.72

1.2

1.3

1.57

1.51

g/l

—

199

Non-small cell lung cancer

424

0.32

4.72

1.1

1.3

1.41

1.52

g/l

1.01

424

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

269

0.26

4.71

1.0

1.2

1.26

1.49

g/l

—

269

Emphysema

501

0.38

4.70

1.2

1.55

1.50

g/l

0.33

501

Conduct disorder

534

0.40

4.68

1.1

1.42

1.47

g/l

0.46

534

Acute peritonitis

715

0.48

4.58

1.1

1.2

1.49

1.52

g/l

0.22

715

L01XE Protein kinase inhibitors

403

0.32

4.55

1.2

1.62

1.55

g/l

0.29

403

Arthropathic psoriasis

136

1959

0.69

4.54

1.1

1.2

1.46

1.53

g/l

1.89

136

1959

Anxious personality disorder

469

0.37

4.53

1.1

1.59

1.52

g/l

0.83

469

Visual disturbances

729

8545

0.85

4.51

1.1

1.51

1.53

g/l

0.83

729

8539

Alzheimer’s disease (Early onset), excluding more controls

230

0.24

4.51

1.0

1.2

1.68

1.56

g/l

—

230

AV-block

987

0.59

4.51

1.1

1.2

1.49

1.51

g/l

0.33

987

Other and unspecified mental retardation

220

0.22

4.50

1.0

1.1

1.28

1.48

g/l

—

220

malignant neoplasm of female genital organs

1306

0.62

4.48

1.1

1.2

1.59

1.62

g/l

0.50

1306

Other disorders of adrenal gland

666

0.47

4.47

1.2

1.1

1.52

1.55

g/l

0.25

666

Speech disturbances, not elsewhere classified

854

0.53

4.45

1.2

1.49

1.53

g/l

0.44

854

Gout, strict definition

1297

0.62

4.45

1.2

1.41

1.46

g/l

1.12

1297

Other diseases of pancreas

903

0.55

4.42

1.2

1.45

1.52

g/l

1.16

903

Behavioural disorders

521

0.41

4.42

1.1

1.41

1.48

g/l

0.63

521

Other follicular disorders

110

1637

0.66

4.42

1.1

1.49

1.52

g/l

0.86

110

1637

Corns and callosities

849

0.53

4.41

1.0

1.2

1.55

1.53

g/l

0.23

849

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

106

1596

0.66

4.40

1.2

1.47

1.52

g/l

1.14

106

1596

Duodenal ulcer

747

0.50

4.40

1.1

1.2

1.55

1.48

g/l

0.70

747

Other and unspecified degenerative diseases of nervous system

112

0.00

4.39

0.0

1.3

—

1.51

—

112

Alzheimer’s disease, strict definition

370

0.37

4.37

1.2

1.3

1.61

1.55

g/l

0.34

370

Inguinal hernia

1156

8709

0.88

4.36

1.1

1.45

1.46

g/l

0.94

1156

8700

Poisoning by narcotics and psychodysleptics [hallucinogens]

386

0.32

4.34

1.1

1.56

1.46

g/l

0.61

386

Colorectal adenocarcinoma

1452

0.65

4.33

1.2

1.55

1.51

g/l

0.70

1452

Traumatic subarachnoid haemorrhage

435

0.36

4.32

1.1

1.33

1.51

g/l

1.93

435

Suppurative and unspecified otitis media

913

9277

0.87

4.31

1.1

1.48

1.50

g/l

0.90

913

9265

Unspecified kidney failure

661

0.48

4.30

1.0

1.2

1.53

1.49

g/l

0.43

661

Benign neoplasm: Colon, unspecified

155

2168

0.71

4.30

1.2

1.50

1.53

g/l

0.83

155

2168

Viral infections of the central nervous system

1315

0.63

4.30

1.1

1.48

1.52

g/l

1.35

1315

Myocardial infarction, without ST-elevation

213

2563

0.75

4.29

1.3

1.2

1.40

1.49

g/l

5.69

213

2563

Endovascular or surgical operations to intracerebral aneurysms

723

0.50

4.28

1.2

1.47

1.55

g/l

1.28

723

Dental operations

1159

6762

0.88

4.26

1.1

1.51

1.52

g/l

0.22

1159

6753

Iron deficiency anaemia secondary to blood loss (chronic)

110

1632

0.67

4.25

1.1

1.2

1.56

1.55

g/l

0.18

110

1632

Other and unspecified local infections of skin and subcutaneous tissue

103

1544

0.66

4.25

1.1

1.2

1.53

1.52

g/l

0.16

103

1544

Hydronephrosis

1243

0.62

4.25

1.1

1.2

1.57

1.53

g/l

0.51

1243

Cirrhosis of liver, NAS

460

0.39

4.22

1.2

1.48

1.50

g/l

0.12

460

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

372

0.32

4.20

1.0

1.2

1.38

1.50

g/l

0.78

372

Pervasive developmental disorders excl. Autism + Asperger

214

0.22

4.20

1.0

1.39

1.46

g/l

—

214

Parkinson's disease, excluding more controls

785

0.55

4.20

1.1

1.2

1.53

g/l

0.04

785

Human immunodeficiency virus [HIV] disease resulting in other conditions

420

0.37

4.15

1.1

1.46

1.44

g/l

0.11

420

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

420

0.37

4.15

1.1

1.46

1.44

g/l

0.11

420

Acute alcohol intoxication ICD-9

381

0.33

4.13

1.0

1.2

1.47

1.49

g/l

0.08

381

Other CVD

1322

0.64

4.13

1.4

1.2

1.48

1.53

g/l

0.94

1322

Pleural effusion

1024

0.59

4.10

1.1

1.2

1.56

1.52

g/l

0.57

1024

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

269

0.29

4.09

1.0

1.2

1.43

1.51

g/l

—

269

Intentional self-harm by unspecified means

278

0.31

4.08

1.0

1.1

1.80

1.50

g/l

—

278

Viral infections of the central nervous system, including avohilmo

1442

0.66

4.06

1.1

1.48

1.52

g/l

1.10

1442

Hypermobility syndrome

1245

0.63

4.05

1.1

1.61

1.58

g/l

0.34

1245

Asthma, hospital admissions , main diagnosis only

1705

16337

0.90

4.00

1.1

1.52

g/l

0.01

1705

16320

Unspecified misadventure during surgical and medical care

693

0.51

4.00

1.2

1.54

g/l

0.06

693

504

0.43

3.99

1.3

1.1

1.57

1.54

g/l

0.20

504

Other local infections of skin and subcutaneous tissue

113

1639

0.68

3.96

1.1

1.2

1.53

1.52

g/l

0.17

113

1639

Migraine with aura

556

6570

0.84

3.96

1.1

1.52

1.57

g/l

4.14

556

6562

Moderate mental retardation

100

0.00

3.94

0.0

1.1

—

1.53

—

100

Tetraplegia

0.00

3.94

0.0

1.1

—

1.52

—

Neuralgia and neuritis, unspecified

930

0.58

3.93

1.2

1.1

1.52

1.55

g/l

0.48

930

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

646

7536

0.85

3.90

1.1

1.51

g/l

0.08

646

7529

Malignant neoplasm of urinary organs, including Hilmo

819

0.56

3.89

1.3

1.2

1.48

1.49

g/l

0.11

819

Panhypopituitarism

221

0.27

3.84

1.2

1.1

1.47

1.52

g/l

—

221

Sequelae of injuries of neck and trunk

465

0.42

3.83

1.0

1.1

1.57

1.50

g/l

0.58

465

Osteonecrosis

694

0.53

3.79

1.1

1.2

1.55

1.52

g/l

0.19

694

Bacterial intestinal infections, IBD co-morbidities

166

2244

0.73

3.79

1.1

1.2

1.47

1.53

g/l

2.34

166

2244

Malignant neoplasm of urinary organs

709

0.53

3.79

1.4

1.2

1.47

1.49

g/l

0.18

709

Unspecified urinary incontinence

848

0.57

3.77

1.2

1.49

1.59

g/l

1.81

848

Diplopia

129

1811

0.71

3.76

1.1

1.52

1.53

g/l

0.13

129

1811

Other blood glucose lowering drugs, excl. Insulins

1328

0.66

3.76

1.2

1.39

1.54

g/l

6.12

1328

Secondary uncertain malignant neoplasm

1194

0.64

3.75

1.3

1.2

1.49

1.51

g/l

0.30

1194

Hyperfunction of pituitary gland

990

0.60

3.73

1.2

1.1

1.52

1.56

g/l

0.50

990

Visual field defects

957

0.60

3.73

1.2

1.52

1.54

g/l

0.19

957

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

247

0.31

3.72

1.0

1.1

1.51

1.45

g/l

—

247

Paranoid personality disorder

313

0.31

3.71

1.3

1.1

1.47

1.54

g/l

—

313

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

755

0.55

3.70

1.3

1.2

1.48

1.49

g/l

0.08

755

Acute gastritis

880

0.58

3.70

1.1

1.2

1.47

1.53

g/l

1.01

880

Late syphilis, including avohilmo

218

0.27

3.69

1.2

1.1

1.51

g/l

—

218

Secondary malignant neoplasm of respiratory and digestive organs

0.00

3.69

0.0

1.3

—

1.53

—

Abnormal weight loss

942

0.60

3.68

1.1

1.49

1.52

g/l

0.46

942

Disorders of muscles

144

1973

0.72

3.66

1.1

1.49

1.52

g/l

0.74

144

1973

Brain glioblastoma and astrocytoma

235

0.29

3.64

1.3

1.2

1.45

1.49

g/l

—

235

Gastric ulcer

1436

0.68

3.61

1.2

1.52

g/l

0.07

1436

Unspecified human immunodeficiency virus [HIV] disease

229

0.29

3.60

1.0

1.1

1.55

1.44

g/l

—

229

Disorders of mineral metabolism

1107

0.63

3.60

1.1

1.2

1.52

1.54

g/l

0.26

1107

Intracerebral haemorrhage

771

0.57

3.55

1.2

1.54

1.50

g/l

0.38

771

Immunodeficiencies

715

0.55

3.54

1.4

1.1

1.62

1.54

g/l

0.85

715

Sleep disorders, other/unspecified

789

0.57

3.54

1.2

1.1

1.51

1.53

g/l

0.20

789

Cerebral palsy

332

0.35

3.51

1.2

1.1

1.52

1.49

g/l

0.14

332

Malignant neoplasm of kidney, except renal pelvis

664

0.54

3.49

1.3

1.2

1.49

g/l

0.04

664

Malignant neoplasm of colon, including Hilmo

1337

0.67

3.49

1.2

1.54

1.52

g/l

0.28

1337

Other peripheral vascular diseases

1122

0.64

3.48

1.1

1.57

1.55

g/l

0.33

1122

Etanercept

1322

0.67

3.47

1.1

1.52

1.54

g/l

0.16

1322

Alzheimer’s disease (Early onset)

214

0.28

3.47

1.0

1.2

1.68

1.57

g/l

—

214

Diseases of peritoneum

1194

0.66

3.46

1.2

1.48

1.54

g/l

1.55

1194

Other respiratory diseases principally affecting the interstitium

1244

0.66

3.45

1.1

1.2

1.53

1.52

g/l

0.12

1244

Blood alcohol or alcohol intoxication level

483

0.46

3.44

1.0

1.1

1.59

1.49

g/l

1.01

483

Other general symptoms and signs

1033

0.63

3.43

1.0

1.1

1.53

1.54

g/l

0.19

1033

Systemic atrophies primarily affecting the central nervous system

347

0.37

3.43

1.0

1.2

1.42

1.54

g/l

0.91

347

6-mercaptopurine

855

0.59

3.42

1.1

1.46

1.50

g/l

0.71

855

Poisoning by medicine, drug-induced

239

0.32

3.41

1.0

1.1

1.69

1.51

g/l

—

239

Aortic valve malfunction, age under 60 years

137

1864

0.73

3.39

1.1

1.47

1.49

g/l

0.52

137

1864

Other abnormal findings of blood chemistry

680

0.55

3.39

1.2

1.1

1.46

1.54

g/l

1.15

680

Fitting and adjustment of other devices

277

3042

0.80

3.39

1.2

1.51

1.54

g/l

1.11

277

3042

Other and unspecified follicular disorders

754

0.57

3.38

1.1

1.48

1.51

g/l

0.28

754

Acute suppurative otitis media

708

7553

0.87

3.38

1.1

1.47

1.49

g/l

1.79

708

7543

Kela-code for behavioural disturbances in mental retardation

0.00

3.36

0.0

1.1

—

1.56

—

Polyuria

188

2450

0.76

3.36

1.1

1.2

1.51

1.52

g/l

0.14

188

2450

Impacted cerumen

1054

0.64

3.36

1.2

1.53

1.52

g/l

0.09

1054

Valvular operations

1316

0.68

3.33

1.2

1.47

g/l

0.03

1316

Other diseases of hard tissues of teeth

1095

6347

0.89

3.32

1.1

1.51

g/l

0.26

1095

6342

Amputation of thigh

0.00

3.32

0.0

1.2

—

1.54

—

Fungal Sepsis

425

0.44

3.31

1.1

1.59

1.54

g/l

0.25

425

Assault by other specified means

236

0.33

3.29

1.0

1.1

1.66

1.51

g/l

—

236

Other complications of surgical and medical care, not elsewhere classified

114

1591

0.71

3.29

1.1

1.50

1.54

g/l

1.02

114

1591

Metatarsalgia

128

1752

0.72

3.28

1.1

1.58

1.57

g/l

0.21

128

1752

Other joint disorders

2343

13178

0.92

3.26

1.1

1.50

1.51

g/l

1.70

2338

13168

Colectomy operation

116

1615

0.71

3.26

1.2

1.57

1.52

g/l

1.17

116

1615

Hemiplegia

620

0.54

3.24

1.2

1.1

1.48

1.55

g/l

0.86

620

Hydrocephalus

543

0.51

3.23

1.1

1.2

1.58

1.52

g/l

0.63

543

Extreme obesity with alveolar hypoventilation

527

0.50

3.22

1.1

1.2

1.40

1.54

g/l

1.62

527

Other diseases of biliary tract

798

0.60

3.22

1.2

1.54

g/l

0.05

798

Postprocedural musculoskeletal disorders, not elsewhere classified

682

0.57

3.19

1.0

1.2

1.55

g/l

0.03

682

Autoimmune hepatitis, wide definition

755

0.59

3.19

1.1

1.52

1.53

g/l

0.13

755

Multiple myeloma, including Hilmo

250

0.36

3.18

1.4

1.2

1.53

1.52

g/l

—

250

Previous suicide attempt

213

0.32

3.15

1.1

1.59

1.52

g/l

—

213

Unspecified privation

123

1683

0.72

3.15

1.1

1.48

1.51

g/l

0.97

123

1683

Unspecified abortion

1055

0.65

3.14

1.3

1.1

1.63

1.64

g/l

0.15

1055

Menorrhagia

542

3525

0.85

3.14

1.1

1.56

1.60

g/l

2.35

542

3519

Focal brain injury

986

0.64

3.13

1.0

1.2

1.50

1.49

g/l

0.12

986

Other disorders of nervous system

827

0.61

3.13

1.2

1.53

g/l

0.02

827

Dermatophytosis

147

1957

0.75

3.12

1.1

1.2

1.48

1.51

g/l

0.77

147

1957

Small fibre neuropathy

316

0.37

3.12

1.1

1.2

1.62

1.51

g/l

0.66

316

356

0.41

3.11

1.1

1.50

1.53

g/l

0.17

356

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

230

0.34

3.11

1.1

1.63

1.54

g/l

—

230

Osteoporosis with pathological fracture (FG)

345

0.40

3.09

1.1

1.2

1.62

1.63

g/l

0.03

345

Open wound of abdomen, lower back and pelvis

607

0.55

3.08

1.1

1.53

1.48

g/l

0.59

607

Polyarthritis, unspecified

505

0.51

3.08

1.1

1.2

1.49

1.54

g/l

0.39

505

ILD, hospital admission 2, with pulmonary infections

726

0.59

3.07

1.1

1.2

1.57

1.52

g/l

0.49

726

Prurigo nodularis

247

0.36

3.07

1.1

1.2

1.55

1.57

g/l

—

247

False labour

819

5737

0.88

3.07

1.1

1.58

1.60

g/l

1.94

819

5732

Malignant neoplasm of pancreas, including Hilmo

520

0.52

3.06

1.1

1.2

1.51

1.52

g/l

0.04

520

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1376

9720

1.10

3.05

1.1

1.60

1.58

g/l

1.30

1376

9710

Atrial septal defect, secundum type

380

0.44

3.04

1.1

1.53

1.54

g/l

0.09

380

Astigmatism

1095

0.67

3.03

1.1

1.45

1.52

g/l

1.85

1095

Any operation in hilmo

154

1042

0.75

3.01

1.1

1.49

g/l

0.06

154

1042

Primary_lymphoid and hematopoietic malignant neoplasms

170

2209

0.77

3.01

1.2

1.48

1.51

g/l

0.62

170

2209

Osteopathy in diseases classified elsewhere

0.00

3.00

0.0

1.2

—

1.57

—

Anorexia (incl.atypical)

1246

0.69

3.00

1.1

1.66

1.55

g/l

3.22

1246

Other enthesopathy of foot (+metatarsalgia)

148

1952

0.75

2.99

1.1

1.56

1.57

g/l

0.24

148

1952

Intestinal adhesions without obstruction

855

0.63

2.99

1.2

1.54

g/l

0.07

855

Habit and impulse disorders

402

0.46

2.98

1.0

1.1

1.44

1.47

g/l

0.25

402

Superficial injury of hip and thigh

139

1851

0.75

2.97

1.1

1.49

1.52

g/l

0.73

139

1851

Melanocytic naevi, other sites/unspecified

113

1548

0.72

2.96

1.1

1.52

1.54

g/l

0.37

113

1548

Hyperprolactinaemia

749

0.60

2.96

1.2

1.1

1.56

1.58

g/l

0.19

749

Unknown and unspecified causes of morbidity

1186

0.68

2.95

1.2

1.1

1.49

1.53

g/l

0.75

1186

Mixed conductive and sensorineural hearing loss

1165

0.68

2.95

1.1

1.2

1.49

1.55

g/l

1.54

1165

Myocarditis

1027

0.66

2.93

1.1

1.45

1.50

g/l

0.99

1027

Other infectious diseases

850

0.63

2.93

1.1

1.47

1.53

g/l

0.85

850

Faecal incontinence

899

0.64

2.92

1.1

1.2

1.59

1.60

g/l

0.12

899

Chronic ulcer of skin, not elsewhere classified

626

0.57

2.92

1.0

1.2

1.47

1.51

g/l

0.39

626

Somnolence, stupor and coma

535

0.53

2.91

1.2

1.1

1.58

1.50

g/l

0.82

535

Hyperkalaemia

377

0.45

2.91

1.2

1.46

1.50

g/l

0.16

377

Left ventricular outflow tract obstruction (LVOTO), broad definition

152

1987

0.76

2.91

1.1

1.46

1.49

g/l

0.69

152

1987

Parkinson's disease, strict definition, excluding more controls

690

0.61

2.90

1.1

1.2

1.52

g/l

0.01

690

Late syphilis

172

0.28

2.88

1.2

1.1

1.54

1.50

g/l

—

172

Enduring personality changes

0.00

2.87

0.0

1.1

—

1.52

—

Later onset COPD

292

0.44

2.87

1.2

1.5

1.54

1.53

g/l

0.11

292

Viral pneumonia (known virus, not influenza)

274

0.36

2.86

1.2

1.1

1.61

1.52

g/l

—

274

Later onset COPD, excluding more controls

277

0.44

2.86

1.2

1.5

1.55

1.53

g/l

0.07

277

Idiopathic pulmonary fibrosis

290

0.38

2.85

1.3

1.2

1.52

g/l

0.03

290

Peripheral arterial reconstruction

649

0.58

2.85

1.1

1.3

1.45

1.50

g/l

0.45

649

Motor neuron disease (with DMD)

174

0.28

2.85

1.0

1.2

1.36

1.56

g/l

—

174

Radial styloid tenosynovitis [de Quervain]

1268

0.70

2.84

1.1

1.51

1.57

g/l

1.29

1268

Toxic effect of ethanol

827

0.63

2.84

1.1

1.49

g/l

0.05

827

Chronic hepatitis, not elsewhere classified

477

0.52

2.83

1.1

1.48

1.55

g/l

0.81

477

Implicit fungal Sepsis

385

0.46

2.83

1.1

1.2

1.58

1.55

g/l

0.15

385

Gluteal tendinitis

705

0.60

2.82

1.1

1.2

1.60

g/l

0.02

705

Unattended death

0.00

2.81

0.0

1.2

—

1.56

—

Monoarthritis, not elsewhere classified

704

0.60

2.81

1.1

1.47

1.53

g/l

1.05

704

Use of interferon beta-1a

524

0.54

2.81

1.1

1.64

1.57

g/l

0.73

524

Unspecified event, undetermined intent

447

0.50

2.79

1.1

1.53

1.50

g/l

0.12

447

Injury of nerves and spinal cord at neck level

269

0.36

2.77

1.1

1.68

1.51

g/l

—

269

Generalized epilepsy

822

0.63

2.76

1.0

1.1

1.53

1.52

g/l

0.06

822

Cardiomyopathy, other and unspecified

885

0.65

2.75

1.2

1.47

1.50

g/l

0.38

885

Other symptoms and signs involving the urinary system

1241

0.70

2.75

1.1

1.2

1.46

1.50

g/l

0.70

1241

Colon adenocarcinoma

716

0.61

2.75

1.3

1.2

1.57

1.51

g/l

0.84

716

Evidence of alcohol involvement determined by level of intoxication

217

0.36

2.75

1.0

1.1

1.63

1.51

g/l

—

217

Cerebral cysts

1037

0.68

2.74

1.1

1.52

g/l

0.03

1037

Impingement syndrome of shoulder

313

3753

0.83

2.73

1.1

1.2

1.53

1.54

g/l

0.16

313

3753

Failure and rejection of transplanted organs and tissues

215

0.36

2.73

1.0

1.1

1.63

1.48

g/l

—

215

Malignant neoplasm of rectum, including Hilmo

945

0.66

2.73

1.2

1.54

1.51

g/l

0.39

945

Other disorders of bladder

1099

0.69

2.72

1.3

1.2

1.52

1.50

g/l

0.18

1099

ILD, hospital admissions 3, with pneumonia sepsis

525

0.55

2.72

1.1

1.2

1.57

1.52

g/l

0.38

525

Use of memantine

308

0.47

2.72

1.2

1.3

1.54

1.52

g/l

0.11

308

Use of other anti-dementia drugs

308

0.47

2.72

1.2

1.3

1.54

1.52

g/l

0.11

308

Viral encephalitis, not elsewhere classified/unspecified

229

0.39

2.71

1.2

1.1

1.45

1.53

g/l

—

229

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

230

0.38

2.71

1.2

1.1

1.45

1.53

g/l

—

230

Hidradenitis suppurativa

889

0.65

2.71

1.0

1.1

1.48

1.53

g/l

1.11

889

Migraine without aura

508

5843

0.86

2.70

1.1

1.53

1.57

g/l

2.67

508

5836

Abnormalities of gait and mobility

978

0.67

2.69

1.2

1.46

1.53

g/l

1.20

978

Vitamin B12 deficiency anaemia

724

0.62

2.69

1.1

1.2

1.56

1.55

g/l

0.00

724

Endocarditis

363

0.46

2.68

1.1

1.37

1.47

g/l

1.09

363

Open wound of thorax

291

0.40

2.68

1.1

1.55

1.47

g/l

0.51

291

Malignant neoplasm of corpus uteri, including Hilmo

573

0.57

2.67

1.1

1.2

1.60

1.63

g/l

0.28

573

Other and unspecified disorders of skin and subcutaneous tissue

745

0.62

2.67

1.1

1.2

1.44

1.55

g/l

2.99

745

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1299

8738

1.10

2.65

1.1

1.61

1.60

g/l

0.41

1299

8728

Non-small cell lung cancer, adenocarcinoma

279

0.39

2.64

1.2

1.3

1.41

1.53

g/l

0.77

279

Familial hypercholesterolemia, with ischemic heart disease

367

1.56

2.64

1.3

1.2

1.47

1.48

g/l

0.21

367

Malignant neoplasm of pancreas

389

0.49

2.64

1.1

1.2

1.53

1.52

g/l

0.03

389

Skin changes due to chronic exposure to nonionizing radiation

137

1628

0.76

2.64

1.2

1.3

1.59

1.55

g/l

0.91

137

1628

Other ulcerative colitis

1156

0.70

2.63

1.1

1.50

1.51

g/l

0.22

1156

Alzheimer’s disease (Late onset), excluding more controls

132

0.34

2.61

1.0

1.5

1.49

1.57

g/l

—

132

Malignant neoplasm of ovary, including Hilmo

593

0.58

2.61

1.0

1.2

1.62

g/l

0.02

593

Other disorders of kidney and ureter

106

1437

0.73

2.61

1.1

1.2

1.51

1.52

g/l

0.13

106

1437

Other infectious diseases, including avohilmo

1111

0.70

2.61

1.1

1.2

1.47

1.53

g/l

1.05

1111

Suppurative and necrotic conditions of lower respiratory tract

579

0.58

2.60

1.1

1.2

1.43

1.48

g/l

0.63

579

Malignant neoplasm of head and neck, including Hilmo

921

0.67

2.59

1.2

1.54

1.49

g/l

0.61

921

Other bursopathies

151

1945

0.77

2.59

1.2

1.51

1.53

g/l

0.32

151

1945

Other interstitial pulmonary diseases

1016

0.69

2.57

1.2

1.53

1.52

g/l

0.09

1016

Causalgia

285

0.41

2.55

1.0

1.1

1.47

1.56

g/l

0.62

285

Hypogonadotropic hypogonadism

827

0.65

2.55

1.1

1.28

1.42

g/l

6.54

827

Injury of other and unspecified intrathoracic organs

916

0.67

2.55

1.1

1.2

1.46

1.47

g/l

0.20

916

Unspecified dementia

162

0.33

2.55

1.0

1.2

1.65

1.54

g/l

—

162

Pustulosis palmaris et plantaris

611

0.60

2.54

1.1

1.2

1.57

1.58

g/l

0.09

611

Use of rivastigmine

209

0.38

2.53

1.3

1.70

1.54

g/l

—

209

Undefined dementia

169

0.33

2.52

1.0

1.3

1.65

1.54

g/l

—

169

Interstitial lung disease endpoints

1012

0.69

2.52

1.2

1.53

1.52

g/l

0.08

1012

Interstitial lung disease

1012

0.69

2.52

1.2

1.53

1.52

g/l

0.08

1012

Other epidermal thickening

547

0.58

2.50

1.1

1.44

1.53

g/l

1.54

547

Pre-eclampsia or poor fetal growth

671

7500

0.89

2.47

1.1

1.58

1.59

g/l

0.89

671

7492

Pneumothorax

779

0.65

2.47

1.2

1.1

1.50

1.49

g/l

0.16

779

Attention to artificial openings

311

0.45

2.47

1.1

1.36

1.52

g/l

3.18

311

Inflammatory diseases of the central nervous system

101

1363

0.73

2.47

1.2

1.1

1.52

g/l

0.03

101

1363

ILD, hospital admissions

1007

0.69

2.46

1.2

1.53

1.52

g/l

0.08

1007

Congenital absence of the uterus

4.63

2.46

1.0

1.56

g/l

—

Paralytic ileus

337

0.47

2.45

1.3

1.2

1.45

1.52

g/l

0.42

337

Foreign body in alimentary tract

752

0.64

2.45

1.1

1.54

1.52

g/l

0.31

752

Pneumonia due to Streptococcus pneumoniae

605

0.60

2.44

1.0

1.1

1.50

g/l

0.02

605

640

0.64

2.44

1.3

1.51

1.55

g/l

0.42

640

Otitis externa, unspecified

168

2116

0.79

2.44

1.1

1.50

1.53

g/l

0.70

168

2116

Cramp and spasm

774

0.65

2.43

1.0

1.1

1.52

1.53

g/l

0.09

774

Motor neuron disease ALS

161

0.31

2.43

1.0

1.1

1.36

1.56

g/l

—

161

Fracture of lumbar spine and pelvis

176

2203

0.79

2.43

1.1

1.2

1.56

1.52

g/l

1.17

176

2203

Malignant neoplasm of rectosigmoid junction, including Hilmo

159

0.31

2.42

1.2

1.39

1.53

g/l

—

159

Adenocarcinoma and ductal carcinoma of pancreas

206

0.39

2.42

1.1

1.2

1.55

1.54

g/l

—

206

Other congenital malformations of female genitalia

154

1.89

2.42

1.0

1.1

1.59

1.57

g/l

0.11

154

Artificial opening status

542

0.58

2.42

1.3

1.1

1.44

1.52

g/l

0.90

542

Adenocarcinoma of pancreas

161

0.31

2.41

1.2

1.63

1.55

g/l

—

161

Paraplegia, diplegia of upper limbs

251

0.39

2.41

1.2

1.1

1.65

1.54

g/l

—

251

Cholangitis (primary sclerosing, PSC)

702

0.64

2.41

1.2

1.55

1.52

g/l

0.30

702

Simple and mucopurulent chronic bronchitis

294

0.44

2.41

1.0

1.1

1.49

1.54

g/l

0.27

294

Disorders of calcium metabolism

713

0.64

2.40

1.1

1.56

1.55

g/l

0.09

713

Nonalcoholic fatty liver disease

153

1942

0.78

2.39

1.2

1.1

1.45

1.52

g/l

2.59

153

1942

Colon adenocarcinoma, helper endpoint

689

0.64

2.37

1.3

1.2

1.57

1.51

g/l

0.76

689

Right hemicolectomy

373

0.51

2.37

1.2

1.64

1.53

g/l

0.83

373

Imperforate hymen

3.86

2.37

1.0

1.60

1.61

g/l

—

Multiple myeloma and malignant plasma cell neoplasms

250

0.40

2.36

1.4

1.2

1.54

g/l

—

250

Seborrhoeic dermatitis

114

1502

0.75

2.36

1.2

1.47

1.51

g/l

1.06

114

1502

Malignant neoplasm of colon

1031

0.70

2.34

1.2

1.57

1.52

g/l

0.73

1031

Meningitis

838

0.67

2.34

1.1

1.54

1.52

g/l

0.16

838

Nystagmus and other irregular eye movements

203

0.39

2.33

1.0

1.1

1.54

1.55

g/l

—

203

Collagenous colitis

1248

0.73

2.33

1.2

1.1

1.50

1.55

g/l

0.79

1248

Abnormal spermatozoa

865

0.68

2.33

1.2

1.40

1.43

g/l

0.35

865

Other embolism and thrombosis

125

1624

0.76

2.32

1.1

1.2

1.54

1.53

g/l

0.09

125

1624

Follow-up examination after treatment for malignant neoplasms

876

0.68

2.32

1.1

1.2

1.58

g/l

0.04

876

Non-small cell lung cancer, adenocarcinoma, helper endpoint

262

0.42

2.31

1.2

1.41

1.54

g/l

0.86

262

Discitis, unspecified

155

0.32

2.30

1.0

1.2

1.38

1.52

g/l

—

155

Familial hypercholesterolemia

128

981

1.31

2.30

1.2

1.51

g/l

0.00

128

981

Congenital iodine-deficiency syndrome/hypothyroidism

286

0.45

2.27

1.2

1.1

1.54

1.59

g/l

0.29

286

Ehlers-Danlos syndrome

211

0.41

2.26

1.0

1.1

1.54

1.57

g/l

—

211

Malignant neoplasm of oesophagus, including Hilmo

258

0.42

2.25

1.0

1.2

1.49

1.46

g/l

0.15

258

Benign neoplasm: Skin of trunk

579

0.61

2.25

1.1

1.41

1.55

g/l

2.79

579

Pustular psoriasis

664

0.64

2.24

1.1

1.2

1.57

g/l

0.04

664

Lesion of lateral popliteal nerve

736

0.66

2.24

1.1

1.2

1.47

1.51

g/l

0.60

736

Other specified/unspecified systemic involvement of connective tissue

807

0.67

2.23

1.2

1.1

1.56

1.58

g/l

0.34

807

Disorders of synovium and tendon in diseases classified elsewhere

336

0.50

2.23

1.3

1.2

1.41

1.52

g/l

0.77

336

Other inflammatory liver diseases

900

0.69

2.21

1.2

1.55

1.52

g/l

0.38

900

Other diseases of spinal cord

426

0.55

2.21

1.2

1.1

1.51

1.53

g/l

0.21

426

Drug-induced adrenocortical insufficiency

240

0.41

2.20

1.3

1.1

1.58

1.60

g/l

—

240

Actinic keratosis

126

1478

0.77

2.19

1.2

1.3

1.59

1.55

g/l

0.93

126

1478

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

539

0.61

2.17

1.3

1.2

1.52

1.57

g/l

0.50

539

Nummular dermatitis

1049

0.72

2.17

1.1

1.2

1.51

1.52

g/l

0.15

1049

Cystic kidney disease

411

0.55

2.17

1.0

1.1

1.41

1.52

g/l

1.01

411

Vascular diseases of the intestine

198

0.40

2.17

1.4

1.2

1.59

1.55

g/l

—

198

Juvenile arthritis (FINNGEN)

1010

0.71

2.16

1.1

1.50

1.53

g/l

0.45

1010

Viral meningitis

763

0.67

2.16

1.1

1.50

1.53

g/l

0.38

763

Sequelae of infectious and parasitic diseases

1218

0.74

2.15

1.1

1.2

1.47

1.51

g/l

0.92

1218

Other and unspecified iridocyclitis

776

0.67

2.15

1.0

1.1

1.46

1.53

g/l

1.31

776

Car occupant injured in noncollision transport accident

726

0.66

2.13

1.1

1.48

1.49

g/l

0.17

726

Sequelae of infectious and parasitic diseases, including avohilmo

1228

0.74

2.13

1.1

1.47

1.51

g/l

0.87

1228

Other coagulation defects

1239

0.74

2.13

1.1

1.56

1.55

g/l

0.18

1239

Benign neoplasm: Transverse colon

871

0.70

2.12

1.1

1.2

1.52

g/l

0.00

871

Use of glatiramer acetate

392

0.55

2.11

1.1

1.57

g/l

0.02

392

Other diseases of pericardium

484

0.59

2.11

1.1

1.45

1.52

g/l

0.81

484

Use of donepezil

305

0.50

2.11

1.4

1.3

1.56

1.53

g/l

0.18

305

Epileptic seizures related to drugs

0.00

2.11

0.0

1.1

—

1.50

—

Alcoholic cardiomyopathy

0.00

2.10

0.0

1.2

—

1.48

—

Wet age-related macular degeneration

281

0.48

2.09

1.0

1.3

1.42

1.55

g/l

1.25

281

Social disorders starting during childhood or adolecense, excluding more controls

160

0.36

2.08

1.3

1.1

1.27

1.46

g/l

—

160

Clear cell adenocarcinoma of kidney

394

0.55

2.08

1.4

1.2

1.52

1.50

g/l

0.14

394

Drug-induced obesity

162

0.36

2.07

1.0

1.1

1.46

1.59

g/l

—

162

Fetus and newborn affected by other complications of labour and delivery

4.21

2.07

1.2

1.0

1.30

1.55

g/l

—

Calcific tendinitis of shoulder

1083

0.73

2.07

1.1

1.57

1.58

g/l

0.02

1083

Congenital malformations of cardiac septa

1127

0.74

2.07

1.1

1.45

1.51

g/l

1.67

1127

Impotence

781

0.68

2.05

1.1

1.2

1.38

1.42

g/l

0.53

781

Assault by blunt object

350

0.53

2.05

1.2

1.1

1.36

1.47

g/l

1.36

350

Dystonia

804

0.69

2.05

1.1

1.52

1.56

g/l

0.58

804

Endocrine disorders, other/unspecified

273

0.47

2.05

1.4

1.1

1.45

1.55

g/l

0.60

273

Cystic kidney disease, including avohilmo

454

0.59

2.05

1.0

1.1

1.40

1.52

g/l

1.43

454

Alcoholic gastritis

144

0.34

2.04

1.0

1.1

1.50

1.49

g/l

—

144

Other lack of coordination

161

0.37

2.04

1.0

1.1

1.50

1.55

g/l

—

161

Viral meningitis, including avohilmo

800

0.69

2.03

1.1

1.51

1.52

g/l

0.29

800

Other maltreatment syndromes

810

0.69

2.03

1.1

1.44

1.47

g/l

0.71

810

Scoliosis

109

1410

0.77

2.03

1.1

1.57

1.55

g/l

0.35

109

1410

Asthma and opportunity respiratory infection

300

0.50

2.02

1.1

1.2

1.60

1.57

g/l

0.13

300

Malignant neoplasm of oesophagus

163

0.36

2.02

1.0

1.2

1.55

1.47

g/l

—

163

Other Crohn's disease

122

1552

0.78

2.02

1.0

1.1

1.48

1.50

g/l

0.39

122

1552

Abnormal blood-pressure reading, without diagnosis

753

0.68

2.01

1.1

1.50

1.54

g/l

0.65

753

Malignant neoplasm of rectum

767

0.69

2.01

1.2

1.52

g/l

0.01

767

Aortic aneurysm

139

1712

0.79

2.00

1.2

1.45

1.46

g/l

0.29

139

1712

Other and unspecified epidermal thickening

349

0.54

1.99

1.1

1.40

1.54

g/l

2.26

349

Unspecified acute lower respiratory infection

249

2946

0.84

1.99

1.1

1.45

1.49

g/l

1.42

249

2946

Total colectomy

680

0.67

1.99

1.1

1.62

1.51

g/l

2.19

680

Total colectomy operation

680

0.67

1.99

1.1

1.62

1.51

g/l

2.19

680

Other specified/unspecified inflammatory spondylopathies

1153

0.74

1.98

1.1

1.52

1.54

g/l

0.35

1153

Other and unspecified psoriasis

915

0.71

1.98

1.1

1.2

1.46

1.53

g/l

1.50

915

Muscle strain

678

0.67

1.97

1.1

1.47

1.53

g/l

0.75

678

Sequelae of other and unspecified infectious and parasitic diseases

1164

0.75

1.97

1.1

1.47

1.51

g/l

0.92

1164

Hyperkinetic disorders (excl. ADHD)

440

0.59

1.97

1.1

1.47

1.46

g/l

0.04

440

Other/unspecified rheumatoid arthritis

1042

0.74

1.96

1.1

1.2

1.58

g/l

0.06

1042

Other diseases of stomach and duodenum

632

0.66

1.96

1.2

1.50

1.53

g/l

0.37

632

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

763

0.69

1.96

1.2

1.52

g/l

0.04

763

Macular hole

257

1.57

1.95

1.2

1.3

1.59

g/l

0.03

257

Vitamin deficiency

678

0.67

1.95

1.0

1.1

1.53

1.55

g/l

0.17

678

Vitamin deficiency, wide

678

0.67

1.95

1.0

1.1

1.53

1.55

g/l

0.17

678

Congenital malformations of the musculoskeletal system, not elsewhere classified

280

0.49

1.95

1.1

1.45

1.57

g/l

0.54

280

Cardiodefibrillation

222

2644

0.83

1.95

1.2

1.41

1.48

g/l

4.88

222

2644

Erythema nodosum

422

0.58

1.95

1.2

1.1

1.45

1.58

g/l

2.24

422

Crohn's disease of large intestine

1048

0.73

1.95

1.0

1.1

1.46

1.51

g/l

1.29

1048

Toxic effect of other and unspecified substances

266

0.48

1.95

1.1

1.70

1.50

g/l

1.03

266

Carrier of infectious disease

371

0.56

1.94

1.2

1.1

1.53

1.54

g/l

0.04

371

Lesion of radial nerve

592

0.65

1.93

1.1

1.54

1.51

g/l

0.31

592

Flat foot [pes planus] (acquired)

122

1544

0.78

1.92

1.2

1.1

1.53

1.57

g/l

1.01

122

1544

Blindness or visual impairment, binocular

0.00

1.92

0.0

1.2

—

1.57

—

Abnormal results of function studies

116

1476

0.78

1.91

1.0

1.1

1.50

1.53

g/l

0.39

116

1476

Relapsing polychondritis

3.04

1.91

1.0

1.2

1.59

1.69

g/l

—

Spontaneous rupture of synovium and tendon

1127

0.75

1.91

1.2

1.52

1.54

g/l

0.43

1127

Disturbances of smell and taste

543

0.64

1.91

1.1

1.2

1.47

1.57

g/l

1.70

543

Parkinson's disease, including avohilmo

713

0.69

1.91

1.1

1.3

1.54

1.52

g/l

0.22

713

Ulcerative enterocolitis

565

0.64

1.90

1.1

1.52

1.54

g/l

0.13

565

Other or ill-defined heart diseases

861

0.71

1.90

1.0

1.1

1.44

1.48

g/l

0.59

861

Myocardial infarction, with ST-elevation

1117

0.75

1.90

1.2

1.34

1.47

g/l

4.27

1117

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

1167

0.75

1.89

1.1

1.47

1.51

g/l

0.89

1167

Generalized epilepsy, mode (most common among epilepsy diagnosis)

575

0.65

1.87

1.0

1.1

1.52

1.53

g/l

0.09

575

Personal history of certain other diseases

391

0.58

1.87

1.1

1.47

1.54

g/l

0.57

391

!Aliquae complicationes praecoces traumatis

706

0.69

1.87

1.1

1.52

1.50

g/l

0.23

706

Early complications of trauma

706

0.69

1.87

1.1

1.52

1.50

g/l

0.23

706

Bicipital tendinitis

834

0.71

1.86

1.1

1.2

1.53

g/l

0.06

834

Disorder of the sleep-wake schedule

327

0.54

1.86

1.2

1.1

1.53

1.49

g/l

0.17

327

Use of fingolimod

246

0.47

1.85

1.0

1.1

1.59

1.57

g/l

0.08

246

Divergent concomitant strabismus

115

1456

0.78

1.85

1.2

1.1

1.53

1.54

g/l

0.15

115

1456

Other and unspecified coagulation defects

924

0.73

1.84

1.1

1.60

1.55

g/l

0.65

924

Myeloproliferative diseases

729

0.70

1.84

1.2

1.46

1.53

g/l

1.23

729

Hypoparathyroidism

327

0.54

1.83

1.1

1.2

1.52

1.59

g/l

0.44

327

Malignant neoplasm of bladder

222

0.45

1.82

1.5

1.3

1.40

1.49

g/l

—

222

Need for immunization against other single viral diseases

286

0.51

1.81

1.1

1.44

1.48

g/l

0.25

286

Other acute viral hepatitis

232

0.46

1.81

1.0

1.1

1.48

1.54

g/l

0.31

232

Other and unspecified hydrocephalus

165

0.42

1.81

1.3

1.1

1.54

g/l

—

165

Anogenital herpesviral [herpes simplex] infection

135

1671

0.80

1.80

1.1

1.53

1.54

g/l

0.27

135

1671

Communicating hydrocephalus

167

0.41

1.80

1.1

1.71

1.55

g/l

—

167

Lichen simplex chronicus

486

0.63

1.80

1.0

1.2

1.51

1.55

g/l

0.35

486

Hypercalcemia

351

0.56

1.80

1.1

1.2

1.52

1.55

g/l

0.18

351

Malignant neoplasm of ovary

437

0.61

1.78

1.0

1.2

1.57

1.62

g/l

0.67

437

543

0.65

1.78

1.1

1.53

1.57

g/l

0.55

543

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

373

1.46

1.78

1.0

1.1

1.47

1.45

g/l

0.23

373

Medial epicondylitis

790

0.71

1.77

1.2

1.1

1.48

1.56

g/l

1.87

790

Malignant neoplasm of head and neck

711

0.70

1.76

1.2

1.53

1.49

g/l

0.42

711

Anosmia

368

0.59

1.76

1.2

1.1

1.44

1.56

g/l

2.10

368

Hypothermia

191

0.46

1.75

1.0

1.1

1.69

1.50

g/l

—

191

Parkinson's disease

676

0.69

1.75

1.1

1.3

1.53

1.51

g/l

0.17

676

Malignant neoplasm, without specification of site, including Hilmo

284

0.52

1.75

1.3

1.2

1.49

1.53

g/l

0.35

284

Drug-induced dystonia

0.00

1.75

0.0

1.0

—

1.58

—

Viral conjunctivitis

432

0.61

1.75

1.0

1.1

1.48

1.54

g/l

0.52

432

Personal history of risk-factors, not elsewhere classified

242

0.49

1.74

1.2

1.1

1.50

1.52

g/l

0.09

242

Assault by unspecified means

527

0.65

1.74

1.2

1.1

1.46

1.47

g/l

0.03

527

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Apolipoprotein A-I [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS